chitosan and plga microspheres as drug delivery ... - UniCA Eprints

More documents

Recommendations

Info

1289. References135. Fukushima S.; Kishimoto S.; Takeuchi Y.; Fukushima M. Preparation and evaluation of o/wtype emulsions containing antitumor prostaglandin. Adv. Drug. Deliv. Rev. vol. 45, p. 65-75,2000.136. Okada H.; Toguchi H. Biodegradable microspheres in drug delivery. Crit. Rev. Ther. DrugCarrier Syst. Vol.12, p. 1-99, 1995.137. Yang Y., Chung T.S., Bai X.L., Chan W.K. Effect of preparation conditions on morphologyand release profiles of biodegradable polymeric microspheres containing protein fabricated bydouble-emulsion method. Chem. Eng. Sci. vol. 55, p. 2223–2236, 2000.138. Ghaderi R., Struesson C., Carlfors J. Effect of preparative parameters on the characteristics ofpoly(d,l-lactideco-glocolide) microspheres made by the double emulsion method. Int. J. Pharm.Vol. 141, p. 205–216, 1996.139. Yan C., Resau J.H., Hewetson J.,West M., Rill W.L., Kende M. Characterization andmorphological analysis of protein loaded poly(lactide-co-glycolide) microparticles prepared bywater-in-oil–in-water emulsion technique. J. Control Release. Vol 32, p. 231-241, 1994.140. McGee J.P., Singh M., Li X.M., Qui H., O’Hagen D.T. The encapsulation of a model proteinin poly(d,l-lactideco-glycocide) microparticles of various sizes: an evaluation of processreproduciblity. J. Microencapsul. Vol. 14, p. 197-210, 1997.141. Schlicher E.J.A.M., Postma N.S., Zuidema J., Talsma H., Hennink W.E. Preparation andcharacterisation of poly(d,l-lactic-co-glycolic acid) microspheres containing desferrioxamine. Int.J. Pharm. Vol. 153, p. 235-245, 1997.142. Lin Y.H.E., Vasavada R.C. Studies on microencapsulation of 5-fluorouracil with poly(orthoester) polymers. J. Microencapsul. Vol. 17, p. 1–11, 2000.143. Jeyanthi R., Thanoo B.C., Metha R.C., DeLuca P.P. Effect of solvent removal technique onthe matrix characteristics of polylactide/glcolide microspheres for peptide delivery. J. ControlRelease. Vol. 38, p. 235-244, 1996.144. Jalil R., Nixon J.R. Microencapsulation using poly(l-lactic acid) II: preparative variablesaffecting microcapsule properties. J. Microencapsul. Vol. 7, p. 25-39, 1990a.145. LeCorre, P. LeGuevello, P. Gajan, V. Chevanne, F. LeVerge, R. Preparation andcharacterization of bupivacaine-loaded polylactide and polylactide-co-glycolide microspheres. Int.J. Pharm. Vol. 107, p. 41-49, 1994.146. Ghaderi R., Struesson C., Carlfors J. Effect of preparative parameters on the characteristics ofpoly(d,l-lactideco-glocolide) microspheres made by the double emulsion method. Int. J. Pharm.Vol. 141, p. 205-216, 1996.147. Mogi T., Ohtake N., Yoshida M., Chimura R., Kamaga Y., Ando S., Tsukamoto T., NakajimaT., Uenodan H., Otsuka M., Matsuda Y., Ohshima K., Makino K. Sustained release of 17 β-estradiol from poly(lactide-co-glycocide) microspheres in vitro and in vivo. Colloid Surface B.vol. 17, p. 153-165, 2000.148. Narayani R., Rao K.P. Controlled release of anticancer drug methotrexate from biodegradablegelatin microspheres. J. Microencapsul. Vol. 11, p. 69-77, 1994.149. Narayani R., Rao K.P. pH responsive gelatin microspheres for the oral delivery of anticancerdrug methotrexate. J. Appl. Polym. Sci. vol. 58, p. 1761-1769, 1995.150. Akhtar S., Lewis K. Antisense oligonucleotide delivery to cultured macrophages is improvedby incorporation into sustained-release biodegradable polymer microspheres. Int. J. Pharm. Vol.151, p. 57–67, 1997.151. Sansdrap P., Moes A.J. In vitro evaluation of the hydrolytic degradation of dispersed andaggregated poly(d,l-lactide-co-glycolide) microspheres. J. Control Release. Vol. 43, p. 47-58,1997.152. Bezemer J.M., Radersma R., Grijpma D.W., Dijkstra P.J., Blitterswijk C.A.V., Feijen J.Microspheres for protein delivery prepared from amphiphilic multiblock copolymers 2.Modulation of release rate. J. Control Release. Vol. 67, p. 249-260, 2000.153. Ermis D., Yuksel A. Preparation of spray-dried microspheres of indomethacin andexamination of the effects of coating on dissolution rates. J. Microencapsul. Vol. 16, p. 315-324,1999.
9. References154. Huang Y.Y., Chung T.W., Tzeng T.W. A method using biodegradablepolylactides/polyethylene glycol for drug release with reduced initial burst. Int. J. Pharm. Vol.182, p. 93-100, 1999.155. Jones C.D., Lyon L.A. Synthesis and characterization of multiresponsive core-shell microgels.Macromolecules. Vol. 33, p. 8301-8306, 2000.156. Lee T.H., Wang J., Wang C.H. Double-walled microspheres for the sustained release of ahighly water soluble drug: characterization and irradiation studies. J. Control Release. Vol. 83, p.437-452, 2002.157. Sparnacci K., Laus M., Tondelli L., Magnani L., Bernardi C. Core-shell microspheres bydispersion polymerization as drug delivery systems. Macromol. Chem. Phys. Vol. 203, p. 1364-1369, 2002.158. Zhou S., Deng, X. Yuan, M. Li X. Investigation on preparation and protein release ofbiodegradable polymer microspheres as drug-delivery system. J. Appl. Polym. Sci. vol. 84, p. 778-784, 2002.159. Mathiowitz E., Chickering D.E., Jacob J.S. US Pat. No. 6,197,346, 2001.160. Sakagami M., Kinoshita W., Sakon K., Sato J., Makino Y. Mucoadhesive beclomethasonemicrospheres for powder inhalation: their pharmacokinetics and pharmacodynamics evaluation, J.Control. Release. Vol. 80 p. 207-218, 2002.161. Sakagami M., Sakon K., Kinoshita W., Makino Y. Enhanced pulmonary absorption followingaerosol administration of mucoadhesive powder microspheres, J. Control. Release. Vol. 77, 117-129, 2001.162. Borchard G., Luegen H.L., de Boer A.G., Verhoef J.C., Lehr C.M. Junginger H.E. Thepotential of mucoadhesive polymers in enhancing intestinal peptide drug absorption: III. Effects ofchitosan-glutamate and carbomer on epithelial tight junctions in vitro, J. Control. Release 39(1996) 131– 138.163. Takeuchi H., Matsui Y., Yamamoto H., Kawashima Y., Mucoadhesive properties of carbopolor chitosan-coated liposomes and their effectiveness in the oral administration of calcitonin to rats,J. Control. Release. Vol. 86, p. 235-242, 2003.164. Herrero-Vanrell R., Fernandez-Carballido A., Frutos G., Cadorniga R. Enhancement of themydriatic response to tropicamide by bioadhesive polymers, J. Ocular Pharmacol. Ther. Vol.16, p.419-428, 2000.165. Lim S.T., Forbes B., Martin G.P., Brown M.B. In vivo and in vitro characterization of novelmicroparticulates based on hyaluronan and chitosan hydroglutamate, AAPS PharmSciTech. Vol.2, p. 20, 2001.166. Thompson D.C. Pharmacology of therapeutic aerosols. In Hickey, A.J. (Ed.), PharmaceuticalInhalation Aerosol Technology, Dekker, New York, p. 29-59, 1992.167. Byron P.R., Prediction of drug residence time, in region of the human respiratory tractfollowing aerosol inhalation. J. Pharm. Sci. vol. 75 p. 433-438, 1986.168. Malo J.L., Cartier A., Merland N., Ghezzo It., Burek A., Morris J. and Jennings B.H. Fourtimes-a-daydosing frequency is better than a twice-a-day regimen in subjects requiring a highdoseinhaled steroid, budesonides to control moderate to severe asthma. Am. Rec. Respir. Dis. vol.140, p. 624-628, 1989.169. Patton J.S. and Platz R.M. Pulmonary delivery of peptides and proteins for systemic action.Adv. Drug Del. ReL. vol. 8 p. 179-196, 1992.170. Edwards D.A., Abdelaziz B.J., Langer R. Recent advances in pulmonary drug delivery usinglarge, porous inhaled particles. J Appl Phys. Vol. 85, p. 379-85, 1998.171. Gupta P.K. and Hung C.T., Albumin microspheres: I. Physico-chemical characteristics. J.Microencapsul. vol. 4, p. 427-462, 1989.172. Zeng X.M., Martin G.P. and Marriott C., Tetrandrine delivery to the lung: the optimisation ofthe preparation of albumin microspheres by central composite design. Int. J. Pharm. Vol. 109, p.135-145, 1994.129
Page 1:
European Union Ministero dell’Uni
Page 5 and 6:
Table Of Contents1. GENERAL INTRODU
Page 7:
7.1.4. Release Studies/Stability St
Page 10 and 11:
1. General Introduction1.1. Pulmona
Page 12 and 13:
1. General Introductionmucosa, and
Page 14 and 15:
1. General Introductionis the fact
Page 16 and 17:
1.3. Lung Anatomy1. General Introdu
Page 18 and 19:
1. General Introductionhighly vascu
Page 20 and 21:
201. General Introductionliquid (84
Page 22 and 23:
1. General IntroductionAerosol size
Page 24 and 25:
1. General Introductionof numerous
Page 26 and 27:
1. General Introductionintermittent
Page 28 and 29:
1. General Introductionsphere prepa
Page 30 and 31:
1. General Introductionit, respecti
Page 32 and 33:
1. General Introductionthe subject
Page 34 and 35:
1. General IntroductionA. zahoor et
Page 36 and 37:
2. Chitosan And PLGA2.1. Chitosan a
Page 38 and 39:
2. Chitosan And PLGAfor the prepara
Page 40 and 41:
2. Chitosan And PLGAmainly controll
Page 42 and 43:
2. Chitosan And PLGAAt present, a n
Page 44 and 45:
2. Chitosan And PLGAneed to be a go
Page 46 and 47:
2. Chitosan And PLGAdichloromethane
Page 49 and 50:
3. Aim of the Work49
Page 51:
3. Aim of the WorkBiodegradable mic
Page 54 and 55:
4. RFP Loaded Chitosan Microspheres
Page 56 and 57:
Page 58 and 59:
Page 60 and 61:
Page 62 and 63:
Page 64 and 65:
Page 66 and 67:
Page 68 and 69:
Page 71 and 72:
5. Rifampicin Loaded ChitosanMicros
Page 73 and 74:
Page 75 and 76:
Page 77 and 78: 5. RFP Loaded Chitosan Microspheres
Page 83: 5. RFP Loaded Chitosan Microspheres
Page 86 and 87: 6. RFP Loaded PLGA Microspheres Pre
Page 100 and 101: 100
Page 102 and 103: 7. RFP Loaded PLGA Coated Chitosan
Page 118 and 119: 118
Page 120 and 121: 8. Final Discussion and Conclusions
Page 122 and 123: 9. References9. References1. Fred S
Page 124 and 125: 9. References40. Wayne L.G., Good R
Page 126 and 127: 1269. References88. Carpenter R.L.
Page 130 and 131: 9. References173. Zeng X.M., Martin
Page 132 and 133: 9. References219. Berthold A., Crem
Page 134: 9. Referencesmediates target gene e
show all

chitosan and plga microspheres as drug delivery ... - UniCA Eprints

Create successful ePaper yourself

Delete template?

Save as template?